• SENSEX 77,540.83
    3.11 (+0.00%)
  • BANKNIFTY 57,761.95
    266.05 (+0.46%)
  • HDFC Bank
    732.85 1,020.35(%)
  • Welspun Corp
    2,348.30 2,348.30(%)
  • 360 ONE
    1,190.00 906.20(%)
  • Shadowfax Technologies
    259.85 268.55(%)
  • Hyundai Motor I
    2,210.85 1,658.45(%)
  • Netweb Technol.
    5,675.00 5,675.00(%)
  • Dhoot Transmission
    1,523.85 1,523.85(%)
  • KDDL Ltd
    4,065.00 4,150.00(%)
  • N S D L
    839.00 1,382.00(%)
  • Deepak Nitrite
    1,726.00 1,280.40(%)
  • Pine Labs
    156.25 134.75(%)
  • Balrampur Chini
    714.30 393.40(%)
  • Radico Khaitan
    4,613.30 2,504.60(%)
  • Interglobe Aviat
    5,053.75 3,894.80(%)
  • Hindustan Copper
    581.00 759.20(%)
  • Cupid
    287.95 298.95(%)
  • HDFC AMC
    2,596.70 2,206.05(%)
  • Himadri Special
    650.25 420.00(%)
  • Meesho
    204.40 125.70(%)
  • Shiprocket
    136.72 129.50(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Cian Healthcare Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 74131.0
  • ISIN : INE05BN01027
9.55 0 (4.95%)
  • As on 22 Aug 2026 (EOD)

  • Today’s Low

    9.55

  • Today’s High

    9.55

  • Open

    9.55

  • Perv Close

    9.10

  • 52W Low

    3.17

  • 52W High

    9.55

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    23.88

  • Div & Yield %

    0.00

  • Book Value(₹)

    8.24

  • Debt-Equity Ratio

    4.95

  • AGM Date

    14-Jul-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    1.01

  • Mar.Cap (₹Cr.)

    23.88

  • RONW (%)

    1.33

  • ROCE (%)

    4.65

Score Board

  • Equity (₹ in Cr.)

    25.00

  • BV (₹)

    8.20

  • Sales( ₹ in Cr.)

    28.30

  • NP (in Cr.)

    -7.79

  • NP Var(%)

    -5.0

  • Div%

    0.0

  • CPS (₹)

    -2.30

  • EPS (₹)

    -3.10

  • Traded Value (₹ in Lakhs)

    23.88

  • 52 Week High

    9.55

  • 52 Week Low

    3.17

  • Price BSE

    10.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    23.88

  • P/C Ratio

    -4.40

  • P/E Ratio

    -3.20

  • Price Vs.BV

    -3.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 30.88 58.75 67.56 64.10 72.38 57.05
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 30.88 58.75 67.56 64.10 72.38 57.05
Other Income 0.25 1.06 0.65 0.48 0.21 0.80
Stock Adjustments -0.23 1.62 4.85 6.96 1.28 0.43
Total Income 30.90 61.43 73.06 71.54 73.87 58.28
EXPENDITURE :            
Raw Materials 20.06 35.65 45.80 45.20 44.19 34.03
Power and Fuel Cost 1.02 1.00 0.07 0.06 0.05 0.09
Employee Cost 6.51 7.18 7.76 7.72 6.44 3.96
Other Manufacturing Expenses 2.71 3.79 4.51 5.96 6.78 5.82
Selling and Administration Expenses 2.36 4.22 3.58 4.32 4.24 4.24
Miscellaneous Expenses 13.14 0.96 1.71 2.84 2.65 1.71
Employee Benefit Expenses 6.51 7.18 7.76 7.72 6.44 3.96
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 45.81 52.80 63.42 66.10 64.35 49.84
Operating Profit -14.91 8.62 9.63 5.44 9.52 8.43
Interest 2.16 4.93 4.79 5.25 6.40 5.90
Gross Profit -17.07 3.69 4.84 0.19 3.12 2.53
Depreciation 2.61 3.68 3.64 2.57 2.45 2.45
Profit Before Tax -19.68 0.01 1.20 -2.38 0.67 0.08
Current Tax -0.04 -0.19 0.20 0.00 0.41 0.15
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.02 -0.19 -0.08 -0.10 -0.07 0.00
Reported Net Profit -19.66 0.39 1.08 -2.28 0.33 -0.07
Extraordinary Items -12.24 0.00 0.03 -0.07 -0.08 0.07
Adjusted Net Profit -7.42 0.39 1.05 -2.21 0.41 -0.14
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 1.00 0.62 -0.46 1.81 1.49 1.56
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -18.65 1.00 0.62 -0.46 1.81 1.49
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -7.86 0.16 0.43 -0.91 0.14 -0.03
Earnings Per Share(Adj)-Unit Curr -7.86 0.16 0.43 -0.91 0.14 -0.03
Book Value 16.86 24.73 24.57 24.14 25.62 25.48
Book Value(Adj)-Unit Curr 16.86 24.73 24.57 24.14 25.62 25.48

Shareholding Pattern

  • Promoter Group

    95.00%

  • Public Share Holding

    5.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 4,750,000 4,750,000.00 4,750,000 4,750,000
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 4,750,000 19.00 4,750,000 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 13,750,000 55.00 13,750,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,250,000 21.00 5,250,000 1
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 19,000,000 76.00 19,000,000 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 97,123 0.39 97,123 20
Clearing Members 959 0.00 959 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 27,571 0.11 27,571 18
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 47,325 0.19 47,325 77
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 227,974 0.91 227,974 4
Individuals holding nominal share capital up to Rs. 1 lakh 848,509 3.39 848,509 1,557
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 539 0.00 539 1
Sub Total 1,250,000 5.00 1,250,000 1,680
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 25,000,000 100.00 25,000,000 1,683

Company Background

Cian Healthcare LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Cian Healthcare Ltd
  • BSE Code : 74131.0
  • ISIN : INE05BN01027

  • Incorporation Year

    2003

  • Registered Office

    Milkat No 3339 BNo 1 Phursungi
    From Southside CS NO 227/2, Pune,
    Maharashtra-412308

  • Telephone

    91-020-26982792

  • FAX

  • Chairman

  • Managing Director

    Suraj Zanwar

  • Company Secretary

    Bhushan Ramesh Kulkarni

  • Auditor

    S S R C A & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No S6-2,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Cian Healthcare Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Cian Healthcare 9.55 31.14 30.88 -1.14 0.00
Abbott India 26,245.55 7,217.19 6,929.05 34.54 43.78
Astrazeneca Phar 7,410.50 2,304.07 2,275.58 109.22 27.86
Glaxosmi. Pharma 2,899.60 3,932.76 3,790.20 46.32 58.17
Cipla 1,426.20 20,102.60 18,979.95 37.48 13.88
Novartis India 1,423.40 398.23 356.27 35.94 16.64
Bliss GVS Pharma 582.25 773.53 729.81 54.06 12.51
Amrutanjan Healt 536.60 469.50 451.82 28.74 21.89
Fermenta Biotec. 478.20 474.15 450.25 22.32 18.77
Guj. Themis Bio. 380.90 152.47 150.80 85.21 27.21
Ambalal Sarabhai 45.28 19.52 3.94 83.85 6.77